MedTrace Logo

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

NCT05465616 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-01-24

No results posted yet for this study

Summary

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Viome's Precision Nutrition Program (VPNP)

Nutrition, diet, and possible coaching through Viome application. Precision supplement based on the participants microbiome sample results.

Sponsors & Collaborators

  • Viome

    lead INDUSTRY

Principal Investigators

  • Momchilo Vuyisich · Viome

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-22
Primary Completion
2026-12-13
Completion
2026-12-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465616 on ClinicalTrials.gov